Dyax Corp (DYAX)
Symbol Info
Listed Symbol DYAX
Name Dyax Corp
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2014-12-31
Latest Fiscal Revenue $81,723,000
Latest Fiscal EPS $-0.10
Price Info
21 Day Moving Average $37.8814
21 Day EMA $37.785510
50 Day Moving Average $36.5974
50 Day EMA $35.885090
200 Day EMA $28.308380
200 Day Moving Average 28.236680
52 Week High $38.56
52 Week Low $14.06
52 Week Change $146.060210
Alpha 0.054266
Beta 1.3858
Standard Deviation 0.165663
R2 0.086220
Periods 60
Share Information
10 Day Average Volume 6,578,756
20 Day Average Volume 3,916,353
30 Day Average Volume 3,628,316
50 Day Average Volume 3,390,360
Outstanding Shares 147,184,538
Float Shares 147,184,538
Percent Float 100.00%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 258
Institute Holdings Date 2015-12-31
Institute Bought Previous 3 Months 19,493,496
Institute Holdings Percent 96.900000
Institute Sold Previous 3 Months 12,924,137
Insider Holdings Date 2015-12-31
Insider Bought Previous 3 Months 37,500
Insider Holdings Percent 0.70%
Insider Sold Previous 3 Months -
Insiders Shares Owned -
Price Change
7 Day Price Change $0.3199997
7 Day Percent Change 0.84%
21 Day Price Change $0.7900009
21 Day Percent Change 2.10%
30 Day Price Change $0.7200012
30 Day Percent Change 1.91%
Month To Date Price Change $0.7900
Month To Date Percent 2.10%
90 Day Price Change $11.760000
90 Day Percent Change 44.13%
Quarter To Date $0.790001
Quarter To Date Percent 2.10%
180 Day Price Change $11.580000
180 Day Percent Change 43.16%
200 Day Price Change $11.789999
200 Day Percent Change 44.29%
Year To Date $0.790001
Year To Date Percent 2.10%
Profile
Description
Details
Issue Type CS
Market Cap $5,653,358,105
Sec Type EQS
Auditor PricewaterhouseCoopers LLP
Total Shares Outstanding -
CEO Gustav A. Christensen
Employees 124
Last Audit UQ
Classification
CIK 0000907562
Industry Biotechnology
Sector Healthcare
NAICS Research and Development in Biotechnology (except Nanobiotechnology)(541714)
Info
Address 55 Network Drive
Burlington, MA 1803
Website http://www.dyax.com
Facisimile +1 617 225-2501
Telephone +1 617 225-2500
Email ir@dyax.com
Key Ratios
Profitability
EBIT Margin -18.6
EBITDA Margin -17.6
Pre-Tax Profit Margin -41
Profit Margin Cont -38.29
Gross Margin 85.60
Profit Margin TOT -38.29
Income Statements
Revenue $71,520,000
Revenue Per Share $0.4859
Revenue 3 Years $12.13
Revenue 5 Years $8.85
Valuation Measures
PE Ratio -
Enterprise Value $5,344,973,104
Price To Sales 79.045840
Price To Free Cash -255.9
PE High Last 5 Years -
Price To Book 18.0
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 18.0
Financial Strength
Total Debt To Equity -
Int Coverage -1.6
Current Ratio 11.7
Leverage Ratio 1.4
Quick Ratio 11.3
Long Term Debt To Capital -
Assets
Receivables Turnover 3.4
Invoice Turnover 1.50
Assets Turnover 0.10
Management Effectiveness
Return Assets -10.58
Return On Equity -14.14
Return On Capital -7.46
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DYAX
Dyax
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.